Astilbin Inhibits High Glucose-Induced Inflammation and Extracellular Matrix Accumulation by Suppressing the TLR4/MyD88/NF-κB Pathway in Rat Glomerular Mesangial Cells-Reference-Cited by-同舟云学术

Astilbin Inhibits High Glucose-Induced Inflammation and Extracellular Matrix Accumulation by Suppressing the TLR4/MyD88/NF-κB Pathway in Rat Glomerular Mesangial Cells

Published:2018-10-18 Issue: Volume:9 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Chen Fang,Zhu Xiaoguang,Sun Zhiqiang,Ma Yali

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference40 articles.

1. Inflammation in diabetic nephropathy: moving toward clinical biomarkers and targets for treatment.;Barutta;Endocrine,2015

2. Astilbin inhibits high glucose-induced autophagy and apoptosis through the PI3K/Akt pathway in human proximal tubular epithelial cells.;Chen;Biomed. Pharmacother.,2018

3. CTGF and chronic kidney fibrosis.;Chen;Front. Biosci.,2009

4. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM.;Del Prete;Diabetologia,1997

5. Diabetic nephropathy: a potential savior with ’rotten-egg’ smell.;Dugbartey;Pharmacol. Rep.,2017

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The mechanisms underlying Chinese medicines to treat inflammation in diabetic kidney disease;Journal of Ethnopharmacology;2024-10

2. Natural compounds improve diabetic nephropathy by regulating the TLR4 signaling pathway;Journal of Pharmaceutical Analysis;2024-08

3. Ethanol extract from Astilbe chinensis inflorescence suppresses inflammation in macrophages and growth of oral pathogenic bacteria;PLOS ONE;2024-07-03

4. Targeting key players in Alzheimer’s disease: bioactive compounds from Moringa oleifera , Desmodium gangeticum , and Centella asiatica as potential therapeutics;Journal of Biomolecular Structure and Dynamics;2024-06-17

5. Phillyrin alleviates high glucose-induced oxidative stress and inflammation in HBZY-1 cells through inhibition of the PI3K/Akt signaling pathway;Journal of Pharmacy and Pharmacology;2024-03-20